Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Melo

Showing results (71-80 of 330) with videos related to

Pageof 33
Sort By:
Human Immunology|April 1, 1990
The leukocyte-common antigen (CD45) complex and B-lymphocyte activationH Zola, J V Melo, H N Zowtyj, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|October 30, 2004
High radon exposure in a Brazilian underground coal mineL H S Veiga, V Melo, S Koifman, et al.
British Journal of Haematology|December 19, 1998
The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABLJ Gora-Tybor, M W Deininger, J M Goldman, et al.
Leukemia Research|January 1, 1986
The 14q+ marker in hairy cell leukaemia. A cytogenetic study of 15 casesV Brito-Babapulle, S Pittman, J V Melo, et al.
Leukemia|February 1, 1997
Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemiaA Spencer, T Vulliamy, J Kaeda, et al.
Blood|December 1, 1994
Controls for reverse transcriptase-polymerase chain reaction amplification of BCR-ABL transcriptsJ V Melo, N S Kent, X H Yan, et al.
Blood|July 20, 2002
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336Russell R Hoover, Francois-Xavier Mahon, Junia V Melo, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
Blood|January 1, 1993
The ABL-BCR fusion gene is expressed in chronic myeloid leukemiaJ V Melo, D E Gordon, N C Cross, et al.
Clinical and Experimental Immunology|July 1, 1988
The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangementJ V Melo, L Foroni, V Brito-Babapulle, et al.
Pageof 33

Showing results (71-80 of 330) with videos related to

Sort By:
Pageof 33
Human Immunology|April 1, 1990
The leukocyte-common antigen (CD45) complex and B-lymphocyte activationH Zola, J V Melo, H N Zowtyj, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|October 30, 2004
High radon exposure in a Brazilian underground coal mineL H S Veiga, V Melo, S Koifman, et al.
British Journal of Haematology|December 19, 1998
The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABLJ Gora-Tybor, M W Deininger, J M Goldman, et al.
Leukemia Research|January 1, 1986
The 14q+ marker in hairy cell leukaemia. A cytogenetic study of 15 casesV Brito-Babapulle, S Pittman, J V Melo, et al.
Leukemia|February 1, 1997
Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemiaA Spencer, T Vulliamy, J Kaeda, et al.
Blood|December 1, 1994
Controls for reverse transcriptase-polymerase chain reaction amplification of BCR-ABL transcriptsJ V Melo, N S Kent, X H Yan, et al.
Blood|July 20, 2002
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336Russell R Hoover, Francois-Xavier Mahon, Junia V Melo, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
Blood|January 1, 1993
The ABL-BCR fusion gene is expressed in chronic myeloid leukemiaJ V Melo, D E Gordon, N C Cross, et al.
Clinical and Experimental Immunology|July 1, 1988
The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangementJ V Melo, L Foroni, V Brito-Babapulle, et al.
Pageof 33